| Predictability of pharmaceutical spending in primary health services using Clinical Risk Groups D Vivas-Consuelo, R Usó-Talamantes, JL Trillo-Mata, ... Health Policy 116 (2-3), 188-195, 2014 | 42 | 2014 |
| Pharmaceutical cost and multimorbidity with type 2 diabetes mellitus using electronic health record data C Sancho-Mestre, D Vivas-Consuelo, L Alvis-Estrada, M Romero, ... BMC Health Services Research 16, 1-8, 2016 | 36 | 2016 |
| Pharmaceutical cost management in an ambulatory setting using a risk adjustment tool D Vivas-Consuelo, R Usó-Talamantes, N Guadalajara-Olmeda, ... BMC health services research 14, 1-11, 2014 | 27 | 2014 |
| Measurement of health-related quality by multimorbidity groups in primary health care M Millá-Perseguer, N Guadalajara-Olmeda, D Vivas-Consuelo, ... Health and quality of life outcomes 17, 1-10, 2019 | 17 | 2019 |
| Sistema de Prescripción y dispensación electrónica en la Agencia Valenciana de Salud E De la Poza, I Barrachina Martínez, JL Trillo Mata, R Usó Talamantes El profesional de la información 20 (3), 332-339, 2011 | 11 | 2011 |
| Data envelopment analysis applications on primary health care using exogenous variables and health outcomes S González-de-Julián, I Barrachina-Martínez, D Vivas-Consuelo, ... Sustainability 13 (3), 1337, 2021 | 9 | 2021 |
| Gasto farmacéutico en diabetes mellitus en una región de España según el Clinical Risk Group, 2012 L Alvis-Estrada, D Vivas-Consuelo, V Caballer-Tarazona, ... Revista Gerencia y Políticas de Salud 15 (30), 68-78, 2016 | 7 | 2016 |
| Análisis y desarrollo de un modelo predictivo del gasto farmacéutico ambulatorio ajustado a morbilidad y riesgo clínico R Usó Talamantes Universitat Politècnica de València, 2015 | 7 | 2015 |
| Desarrollo del indicador Población Estandarizada Equivalente para el control del gasto farmacéutico ambulatorio M Caballer Tarazona, L Buigues Pastor, I Saurí Ferrer, R Usó Talamantes, ... Revista Española de Salud Pública 86 (4), 371-380, 2012 | 6 | 2012 |
| Cost of Type 2 diabetes patients with chronic kidney disease based on real-world data: an observational population-based study in Spain R Usó-Talamantes, S González-de-Julián, J Díaz-Carnicero, ... International Journal of Environmental Research and Public Health 18 (18), 9853, 2021 | 5 | 2021 |
| Methods to control the pharmaceutical cost impact of chronic conditions in the elderly D Vivas-Consuelo, R Usó-Talamantes, JL Trillo-Mata, P Mendez-Valera Expert Review of Pharmacoeconomics & Outcomes Research 15 (3), 425-437, 2015 | 5 | 2015 |
| Evaluación de un modelo de predicción del gasto farmacéutico en atención primaria de salud basado en variables demográficas S Santamargarita-Pérez, C Sancho-Mestre, D Vivas-Consuelo, ... Revista Gerencia y Políticas de Salud 12 (25), 55-65, 2013 | 5* | 2013 |
| Análisis y desarrollo de un modelo predictivo del gasto farmacéutico ambulatorio ajustado a morbilidad y riesgo clínico RUSÓ TALAMANTES Universidad Politécnica de València València, 2015 | 4 | 2015 |
| A standardized amount indicator by equivalent patient to control outpatient pharmaceutical expenditure, Spain S Ferrer, TM JL Revista espanola de salud publica 86 (4), 371-380, 2012 | 4 | 2012 |
| Multimorbidity Pharmaceutical Cost of Diabetes Mellitus D Vivas-Consuelo, L Alvis-Estrada, R Uso-Talamantes, ... Value in Health 17 (7), A341-A342, 2014 | 3 | 2014 |
| Health district drug management tools in the comunidad Valenciana health system JL Trillo, R Usó, D Vivas, J Bru, C Sancho, L Buigues, I Saurí, P Mendez IEEE-EMBS International Conference on Biomedical and Health Informatics (BHI …, 2014 | 3 | 2014 |
| PHP45 Predictability of Pharmaceutical Spending Using Clinical Risk Groups in the Valencian Community in Valencia RU Talamantes, MC Tarazona, LB Pastor, JLT Mata, NG Olmeda, ... Value in Health 14 (7), A341, 2011 | 3 | 2011 |
| PMU63-EFFICIENCY ASSESSMENT IN PRIMARY HEALTHCARE CENTERS OF A HEALTH DISTRICT S Gonzalez-De Julian, S Trillez-Araujo, R Uso-Talamantes, VC Tarazona, ... Value in Health 21, S318, 2018 | 2 | 2018 |
| Pharmaceutical expenditure for diabetes mellitus in a region of Spain as clinical Risk Group, 2012 L Alvis-Estrada, D Vivas-Consuelo, V Caballer-Tarazona, ... Revista Gerencia y Politicas de Salud 15 (30), 68-78, 2016 | 2 | 2016 |
| Pharmaceutical Cost Analysis of Diabetes Mellitus Using Clinical Risk Groups in Valencian Community M Romero, RU Talamantes, DV Consuelo, E De la Poza Plaza, ... Value in Health 16 (7), A691, 2013 | 2 | 2013 |
